MedTrace Logo

Antibody Response in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19.

NCT04633915 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2021-08-03

No results posted yet for this study

Summary

This is prospective cohort study aimed to compare antibody response against SARS-CoV-2 in dialysis patients and non-dialysis-dependent volunteers.

The research hypothesis is that dynamic of IgG antibodies against SARS-CoV-2 will differ in two groups.

To determine whether there is a statistically significant interaction between factors "group" and "time" on the titer of IgG antibodies against SARS-CoV-2, a two-way repeated measures ANOVA will be used.

Conditions

  • Dialysis
  • Covid19

Sponsors & Collaborators

  • Saint Petersburg State University, Russia

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-26
Primary Completion
2021-07-18
Completion
2021-07-18

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04633915 on ClinicalTrials.gov